Trials / Completed
CompletedNCT01192802
Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora
Effect of Intestinal Helminths on Gut Microflora
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Albert Schweitzer Hospital · Academic / Other
- Sex
- All
- Age
- 4 Years – 14 Years
- Healthy volunteers
- Accepted
Summary
Albendazole is a main anti-helminth, however there is a lack of data regarding its efficacy in the school children population. The aim of this study is to evaluate the efficacy of the albendazole one versus two and three doses, in school children infected with intestinal helminth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | albendazole | 1 tablet of 400 mg of albendazole per day for three consecutive days |
| DRUG | albendazole | single 1 tablet of 400 mg of albendazole |
| DRUG | albendazole | 1 tablet of 400 mg of albendazole per day for two consecutive days |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2010-09-01
- Last updated
- 2013-01-24
Locations
1 site across 1 country: Gabon
Source: ClinicalTrials.gov record NCT01192802. Inclusion in this directory is not an endorsement.